Search Results - "Sanjay, Apoorva Bharthur"
-
1
Characterization of gene expression patterns in mild cognitive impairment using a transcriptomics approach and neuroimaging endophenotypes
Published in Alzheimer's & dementia (01-12-2022)“…Introduction Identification of novel therapeutics and risk assessment in early stages of Alzheimer's disease (AD) is a crucial aspect of addressing this…”
Get full text
Journal Article -
2
Predicting the Emergence of Major Neurocognitive Disorder Within Three Months After a Stroke
Published in Frontiers in aging neuroscience (16-08-2021)“…Background: Neurocognitive disorder (NCD) is common after stroke, with major NCD appearing in about 10% of survivors of a first-ever stroke. We aimed to…”
Get full text
Journal Article -
3
Effect of genetic and vascular AD risk factors on rate of cognitive decline in EOAD vs LOAD
Published in Alzheimer's & dementia (01-12-2021)“…Background APOE ε4 and vascular factors are well‐known risk factors for developing AD. The effect of these risk factors on rate of cognitive decline in early‐…”
Get full text
Journal Article -
4
Sexually dimorphic association of circulating leptin levels with early amyloid‐beta pathology assessed by amyloid PET
Published in Alzheimer's & dementia (01-12-2021)“…Background Weight loss can precede the cognitive decline in Alzheimer’s Disease (AD), suggesting that mechanisms regulating body weight such as the adipocyte…”
Get full text
Journal Article -
5
Gene co‐expression network analyses in Mild cognitive impairment
Published in Alzheimer's & dementia (01-12-2023)“…Background Multiomic data analysis has been extensively developed in recent years. Particularly, microarray data can be used as biomarkers of disease of…”
Get full text
Journal Article -
6
Alzheimer’s Disease mechanistic pathways were discovered through in silico experiments in causal AI based digital twins
Published in Alzheimer's & dementia (01-12-2023)“…Background Beyond a single‐gene‐based approach, pathway‐based approaches have become important in drug development paradigm. Several pathways are known for the…”
Get full text
Journal Article -
7
Gene co‐expression network analyses in Mild cognitive impairment
Published in Alzheimer's & dementia (01-12-2023)“…Background Multiomic data analysis has been extensively developed in recent years. Particularly, microarray data can be used as biomarkers of disease of…”
Get full text
Journal Article -
8
Transcriptomic profiling of brain amyloidosis using peripheral blood‐based gene expression: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers
Published in Alzheimer's & dementia (01-12-2020)“…Abstract Background In an effort towards pre‐symptomatic risk assessment, precision medicine and biomarker development in AD, we evaluated the efficacy of…”
Get full text
Journal Article -
9
Transcriptomic profiling of brain amyloidosis using peripheral blood‐based gene expression
Published in Alzheimer's & dementia (01-12-2020)“…Background In an effort towards pre‐symptomatic risk assessment, precision medicine and biomarker development in AD, we evaluated the efficacy of…”
Get full text
Journal Article -
10
Chromosome 19 polygenic risk scores defined by deep learning model predict the rate of Alzheimer’ disease progression
Published in Alzheimer's & dementia (01-06-2023)“…Background Genetic variants invariably play a crucial role in rate of disease progression. The effects of Alzheimer’s disease (AD) genetic risk factors on…”
Get full text
Journal Article -
11
Transcriptomic profiling of brain amyloidosis and Alzheimer’s disease phenotypes identifies novel gene targets from peripheral blood gene expression data
Published in Alzheimer's & dementia (01-06-2023)“…Background In an effort towards pre‐symptomatic risk assessment, precision medicine and biomarker development in AD, we evaluated the efficacy of…”
Get full text
Journal Article -
12
Transcriptomic profiling in mild cognitive impairment using peripheral blood gene co‐expression networks
Published in Alzheimer's & dementia (01-12-2021)“…Background In an effort towards AD prodromal risk assessment, precision medicine and biomarker development, we evaluated the efficacy of characterizing and…”
Get full text
Journal Article -
13
Characterization of genetic expression patterns in MCI using a multiomics approach and neuroimaging endophenotypes
Published in Alzheimer's & dementia (01-12-2020)“…Background Our goal was to characterize gene expression patterns at the MCI stage using a multiomics approach involving the integration of neuroimaging MRI…”
Get full text
Journal Article -
14
Characterization of genetic expression patterns in MCI using a multiomics approach and neuroimaging endophenotypes: Biomarkers (non‐neuroimaging): EEG and other biomarkers
Published in Alzheimer's & dementia (01-12-2020)“…Abstract Background Our goal was to characterize gene expression patterns at the MCI stage using a multiomics approach involving the integration of…”
Get full text
Journal Article -
15
APOE ε4 carrier status and sex differentiate rates of cognitive decline in early‐ and late‐onset Alzheimer's disease
Published in Alzheimer's & dementia (01-05-2023)“…Background We studied the effect of apolipoprotein E (APOE) ε4 status and sex on rates of cognitive decline in early‐ (EO) and late‐ (LO) onset Alzheimer's…”
Get full text
Journal Article -
16
Early‐onset APOE‐ε4 carriers show greater decline in memory, language and executive function than late‐onset carriers
Published in Alzheimer's & dementia (01-12-2021)“…Background Apolipoprotein‐ε4 (APOE‐ε4) is the strongest genetic risk factor for sporadic Alzheimer’s disease (AD). However, whether APOE‐ε4 accelerates…”
Get full text
Journal Article -
17
PREDICTING BRAIN AMYLOIDOSIS USING PERIPHERAL BLOOD-BASED GENE EXPRESSION AND EARLY STAGE NEURODEGENERATION BIOMARKERS
Published in Alzheimer's & dementia (01-07-2019)Get full text
Journal Article -
18
O1‐03‐03: PREDICTING BRAIN AMYLOIDOSIS USING PERIPHERAL BLOOD‐BASED GENE EXPRESSION AND EARLY STAGE NEURODEGENERATION BIOMARKERS
Published in Alzheimer's & dementia (01-07-2019)Get full text
Journal Article -
19
IC‐P‐051: PREDICTING BRAIN AMYLOIDOSIS USING PERIPHERAL BLOOD‐BASED GENE EXPRESSION AND EARLY STAGE NEURODEGENERATION BIOMARKERS
Published in Alzheimer's & dementia (01-07-2019)Get full text
Journal Article -
20
PREDICTING BRAIN AMYLOIDOSIS USING PERIPHERAL BLOOD-BASED GENE EXPRESSION AND EARLY STAGE NEURODEGENERATION BIOMARKERS
Published in Alzheimer's & dementia (01-07-2019)Get full text
Journal Article